The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
The role of Bcl-2 family members in tumorigenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“Loss of various tumor suppressor genes such as p53, WT1 and PTEN has been shown to cause Bcl-2 overexpression [213].”
BackgroundHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 4×
“Decreased Bax levels in tumors are not surprising given the fact that Bax is a transcriptional target of the tumor suppressor P53 which is mutated in the majority of human cancers [52].”
BackgroundInfluentialThe Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Veis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,493
Lindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00136-2 · Cited by 1,489
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,478
Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476 · cited 1×
“The hydrophobic groove can bind the BH3 a-helix of an interacting (pro-apoptotic) Bcl-2 family member [9].”
BackgroundX-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., et al. (1996) · Nature · doi:10.1038/381335a0 · Cited by 1,467
BAX and BAK Regulation of Endoplasmic Reticulum Ca 2+ : A Control Point for Apoptosis
Scorrano, L., Oakes, S. A., Opferman, J. T., Cheng, E. H., Sorcinelli, M. D., Pozzan, T., & Korsmeyer, S. J. (2003) · Science · doi:10.1126/science.1081208 · Cited by 1,385
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.16.2060 · Cited by 1,268
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252 · cited 1×
“Also well studied are the cells of the immune system and among them lymphocytes [59].”
BackgroundCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,217
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Animals that bear a transcriptionally deregulated bcl-2 transgene targeted to the lymphoid compartment show splenic hyperplasia and a general high survival of explanted B-cells, but at first no development of overt lymphoma [89,90].”
BackgroundWang, J.-L., Liu, D., Zhang, Z.-J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,179
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BAD
Wang, H.-G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., & Reed, J. C. (1999) · Science · doi:10.1126/science.284.5412.339 · Cited by 1,132
Conversion of Bcl-2 to a Bax-like Death Effector by Caspases
Cheng, E. H.-Y., Kirsch, D. G., Clem, R. J., Ravi, R., Kastan, M. B., Bedi, A., Ueno, K., & Hardwick, J. M. (1997) · Science · doi:10.1126/science.278.5345.1966 · Cited by 1,107
Suzuki, M., Youle, R. J., & Tjandra, N. (2000) · Cell · doi:10.1016/s0092-8674(00)00167-7 · Cited by 1,101
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,043
The mitochondrion in apoptosis: how Pandora's box opens
Zamzami, N., & Kroemer, G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048073 · Cited by 1,028
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas
Horning, S. J., & Rosenberg, S. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412063112303 · Cited by 909
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Role of BAX in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863
Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., & Harris, A. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8661 · Cited by 862
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
Zong, W.-X., Lindsten, T., Ross, A. J., MacGregor, G. R., & Thompson, C. B. (2001) · Genes & Development · doi:10.1101/gad.897601 · Cited by 808
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes
Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L.-C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J. M., & Strasser, A. (2002) · Nature · doi:10.1038/415922a · Cited by 782
Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 743
Conformation of the Bax C-terminus regulates subcellular location and cell death
Nechushtan, A., Smith, C. L., Hsu, Y.-T., & Youle, R. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2330 · Cited by 739
The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
Borner, C. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(02)00252-3 · Cited by 703
Antonsson, B., Montessuit, S., Sanchez, B., & Martinou, J.-C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010810200 · Cited by 676
Puthalakath, H., Villunger, A., O'Reilly, L. A., Beaumont, J. G., Coultas, L., Cheney, R. E., Huang, D. C. S., & Strasser, A. (2001) · Science · doi:10.1126/science.1062257 · Cited by 656
Bax suppresses tumorigenesis and stimulates apoptosis in vivo
Yin, C., Knudson, C. M., Korsmeyer, S. J., & Dyke, T. V. (1997) · Nature · doi:10.1038/385637a0 · Cited by 654
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.
Krajewski, S., Krajewska, M., Shabaik, A. S., Miyashita, T., Wang, H., & Reed, J. C. (1994) · PubMed · Cited by 650
Antonsson, B. E., Montessuit, S., Lauper, S., Eskes, R., & Martinou, J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450271 · Cited by 645
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A. S., Sauvageot, J., Song, K. B., Kitada, S., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 593
Molecular mechanisms of “detachment-induced apoptosis—Anoikis”
Grossmann, J. (2002) · Apoptosis · doi:10.1023/a:1015312119693 · Cited by 565
Zha, J., Weiler, S., Oh, K. J., Wei, M. C., & Korsmeyer, S. J. (2000) · Science · doi:10.1126/science.290.5497.1761 · Cited by 558
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Bcl-X L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
Hu, Y., Benedict, M. A., Wu, D., Inohara, N., & Núñez, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4386 · Cited by 529
Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex
Pan, G., O'Rourke, K., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5841 · Cited by 521
Mounier, N. (2003) · Blood · doi:10.1182/blood-2002-11-3442 · Cited by 513
LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., & Ashkenazi, A. (2002) · Nature Medicine · doi:10.1038/nm0302-274 · Cited by 507
Hsu, Y.-T., & Youle, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10777 · Cited by 504
Newton, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.706 · Cited by 499
Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2
Schlesinger, P. H., Gross, A., Yin, X.-M., Yamamoto, K., Saito, M., Waksman, G., & Korsmeyer, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11357 · Cited by 492
Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling
Chou, J. J., Li, H., Salvesen, G. S., Yuan, J., & Wagner, G. (1999) · Cell · doi:10.1016/s0092-8674(00)80572-3 · Cited by 488
Griffiths, G. J., Dubrez, L., Morgan, C. P., Jones, N. A., Whitehouse, J., Corfe, B. M., Dive, C., & Hickman, J. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.903 · Cited by 479
Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis
Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S.-H., & Youle, R. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1265 · Cited by 477
Cardiolipin provides specificity for targeting of tBid to mitochondria
Lutter, M., Fang, M., Luo, X., Nishijima, M., Xie, X.-S., & Wang, X. (2000) · Nature Cell Biology · doi:10.1038/35036395 · Cited by 472
Solution structure of the antiapoptotic protein bcl-2
Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T., & Fesik, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041619798 · Cited by 458
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
Tzung, S.-P., Kim, K. M., Basañez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y. J., & Hockenbery, D. M. (2001) · Nature Cell Biology · doi:10.1038/35055095 · Cited by 452
Bcl-2 decreases the free Ca 2+ concentration within the endoplasmic reticulum
Foyouzi-Youssefi, R., Arnaudeau, S., Borner, C., Kelley, W. L., Tschopp, J., Lew, D. P., Demaurex, N., & Krause, K.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5723 · Cited by 432
Derenne, S., Monia, B., Dean, N. M., Taylor, J. K., Rapp, M.-J., Harousseau, J.-L., Bataille, R., & Amiot, M. (2002) · Blood · doi:10.1182/blood.v100.1.194 · Cited by 427
Merry, D. E., Veis, D. J., Hickey, W. F., & Korsmeyer, S. J. (1994) · Development · doi:10.1242/dev.120.2.301 · Cited by 426
DmPAR-6 directs epithelial polarity and asymmetric cell division of neuroblasts in Drosophila
Petronczki, M., & Knoblich, J. A. (2001) · Nature Cell Biology · doi:10.1038/35050550 · Cited by 419
Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
Zamzami, N., Brenner, C., Marzo, I., Susin, S. A., & Kroemer, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201989 · Cited by 414
Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
Limpens, J., Stad, R., Vos, C., de Vlaam, C., de Jong, D., van Ommen, G., Schuuring, E., & Kluin, P. (1995) · Blood · doi:10.1182/blood.v85.9.2528.bloodjournal8592528 · Cited by 410
Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice
Nakayama, K.-I., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., et al. (1993) · Science · doi:10.1126/science.8372353 · Cited by 397
Solution Structure of the Proapoptotic Molecule BID
McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J., & Cowburn, D. (1999) · Cell · doi:10.1016/s0092-8674(00)80573-5 · Cited by 396
Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., & Loh, D. Y. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3700 · Cited by 395
The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry.
O'Reilly, L. A., Huang, D. C., & Strasser, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01090.x · Cited by 377
Hsu, S. Y., Kaipia, A., McGee, E., Lomeli, M., & Hsueh, A. J. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12401 · Cited by 370
McCurrach, M. E., Connor, T. M. F., Knudson, C. M., Korsmeyer, S. J., & Lowe, S. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2345 · Cited by 369
Myeloid cell factor–1 is a critical survival factor for multiple myeloma
Zhang, B., Gojo, I., & Fenton, R. G. (2002) · Blood · doi:10.1182/blood.v99.6.1885 · Cited by 367
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
Kaufmann, S. H., Karp, J. E., Svingen, P. A., Krajewski, S., Burke, P. J., Gore, S. D., & Reed, J. C. (1998) · Blood · doi:10.1182/blood.v91.3.991 · Cited by 365
VDAC regulation by the Bcl-2 family of proteins
Tsujimoto, Y., & Shimizu, S. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400780 · Cited by 337
Huang, D. C. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4628 · Cited by 333
Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.
Linette, G. P., Li, Y., Roth, K., & Korsmeyer, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9545 · Cited by 329
bcl-w, a novel member of the bcl-2 family, promotes cell survival.
Gibson, L., Holmgreen, S. P., Huang, D. C. S., Bernard, O., Copeland, N. G., Jenkins, N. A., Sutherland, G. R., Baker, E. K., Adams, J. M., & Cory, S. (1996) · PubMed · Cited by 307
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.
Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J., & Nuñez, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06307.x · Cited by 301
Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2
Häcki, J., Egger, L., Monney, L., Conus, S., Rossé, T., Fellay, I., & Borner, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203592 · Cited by 301
Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis
Rathmell, J. C., Lindsten, T., Zong, W.-X., Cinalli, R. M., & Thompson, C. B. (2002) · Nature Immunology · doi:10.1038/ni834 · Cited by 297
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens, J., de Jong, D., van Krieken, J. H., Price, C. G. A., Young, B. D., van Ommen, G. B., & Kluin, P. M. (1991) · PubMed · Cited by 287
Hematopoietic Malignancies Demonstrate Loss-of-Function Mutations ofBAX
Meijerink, J. P. P., Mensink, E. J. B. M., Wang, K., Sedlak, T. W., Slöetjes, A. W., de Witte, T., Waksman, G., & Korsmeyer, S. J. (1998) · Blood · doi:10.1182/blood.v91.8.2991.2991_2991_2997 · Cited by 286
Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed · Cited by 283
Oblimersen Bcl-2 Antisense: Facilitating Apoptosis in Anticancer Treatment
Klasa, R. J., Gillum, A. M., Klem, R. E., & Frankel, S. R. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220798 · Cited by 280
Genetic analysis of chemoresistance in primary murine lymphomas
Schmitt, C. A., Rosenthal, C. T., & Lowe, S. W. (2000) · Nature Medicine · doi:10.1038/79542 · Cited by 278
Mazel, S., Burtrum, D., & Petrie, H. T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2219 · Cited by 270
Testicular degeneration in Bclw-deficient mice
Ross, A. J., Waymire, K. G., Moss, J. E., Parlow, A. F., Skinner, M. K., Russell, L. D., & MacGregor, G. R. (1998) · Nature Genetics · doi:10.1038/ng0398-251 · Cited by 269
Holinger, E. P., Chittenden, T., & Lutz, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13298 · Cited by 254
Linette, G. P., Grusby, M. J., Hedrick, S. M., Hansen, T. H., Glimcher, L. H., & Korsmeyer, S. J. (1994) · Immunity · doi:10.1016/1074-7613(94)90098-1 · Cited by 249
Mandic, A., Viktorsson, K., Strandberg, L., Heiden, T., Hansson, J., Linder, S., & Shoshan, M. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.3003-3013.2002 · Cited by 245
Bclx regulates the survival of double-positive thymocytes.
Ma, A., Pena, J. C., Chang, B., Margosian, E., Davidson, L., Alt, F. W., & Thompson, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4763 · Cited by 244
Apoptosis regulators and their role in tumorigenesis
Zörnig, M., Hueber, A.-O., Baum, W., & Evan, G. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00031-2 · Cited by 239
Self-citationAssociation of Bax and Bak Homo-oligomers in Mitochondria
Mikhailov, V., Mikhailova, M., Degenhardt, K., Venkatachalam, M. A., White, E., & Saikumar, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203392200 · Cited by 231
Kamada, S., Shimono, A., Shinto, Y., Tsujimura, T., Takahashi, T., Noda, T., Kitamura, Y., Kondoh, H., & Tsujimoto, Y. (1995) · PubMed · Cited by 225
Kandasamy, K., Srinivasula, S. M., Alnemri, E. S., Thompson, C. B., Korsmeyer, S. J., Bryant, J., & Srivastava, R. K. (2003) · PubMed · Cited by 222
Nuñez, G., Hockenbery, D., McDonnell, T. J., Sorensen, C. M., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/353071a0 · Cited by 211
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Naik, P., Karrim, J., & Hanahan, D. (1996) · Genes & Development · doi:10.1101/gad.10.17.2105 · Cited by 202
Krajewski, S., Krajewska, M., & Reed, J. C. (1996) · PubMed · Cited by 199
Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2
Borner, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12695 · Cited by 198
Bax and Bak Independently Promote Cytochrome cRelease from Mitochondria
Degenhardt, K., Sundararajan, R., Lindsten, T., Thompson, C., & White, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109939200 · Cited by 195
Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118715 · Cited by 189
Gil-Gomez, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7209 · Cited by 184
Werner, A. B., de Vries, E., Tait, S. W. G., Bontjer, I., & Borst, J. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201469200 · Cited by 184
Eischen, C. M., Roussel, M. F., Korsmeyer, S. J., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7653-7662.2001 · Cited by 183
Prokop, A., Wieder, T., Sturm, I., Eβmann, F., Seeger, K., Wuchter, C., Ludwig, W.-D., Henze, G., Dörken, B., & Daniel, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401866 · Cited by 183
Strasser, A., Huang, D. C. S., & Vaux, D. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00019-x · Cited by 180
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity
Hinds, M. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg144 · Cited by 175
Mercatante, D. R., Mohler, J. L., & Kole, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209236200 · Cited by 174
Sturm, I., Köhne, C.-H., Wolff, G., Petrowsky, H., Hillebrand, T., Hauptmann, S., Lorenz, M., Dörken, B., & Daniel, P. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1364 · Cited by 173
Proapoptotic BID is required for myeloid homeostasis and tumor suppression
Zinkel, S. S., Ong, C. C., Ferguson, D. O., Iwasaki, H., Akashi, K., Bronson, R. T., Kutok, J. L., Alt, F. W., & Korsmeyer, S. J. (2003) · Genes & Development · doi:10.1101/gad.1045603 · Cited by 169
Regulation of Apoptosis and Cell Cycle Progression by MCL1
Fujise, K., Zhang, D., Liu, J.-L., & Yeh, E. T. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006626200 · Cited by 168
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
Eischen, C. M., Packham, G., Nip, J., Fee, B. E., Hiebert, S. W., Zambetti, G. P., & Cleveland, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204892 · Cited by 168
Karsan, A., Yee, E., Kaushansky, K., & Harlan, J. (1996) · Blood · doi:10.1182/blood.v87.8.3089.bloodjournal8783089 · Cited by 168
Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival.
Vairo, G., Innes, K. M., & Adams, J. M. (1996) · PubMed · Cited by 168
Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells.
Wang, J., Zhang, Z. J., Choksi, S., Shan, S., Lu, Z., Croce, C. M., Alnemri, E. S., Korngold, R., & Huang, Z. (2000) · PubMed · Cited by 167
Bax alpha perturbs T cell development and affects cell cycle entry of T cells.
Brady, H. J., Gil-Gómez, G., Kirberg, J., & Berns, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01091.x · Cited by 166
Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K., & Krammer, P. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270523 · Cited by 166
Regulation of apoptosis by BH3 domains in a cell-free system
Cosulich, S. C., Worrall, V., Hedge, P. J., Green, S., & Clarke, P. R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00410-6 · Cited by 166
Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells
Jiang, M., & Milner, J. (2003) · Genes & Development · doi:10.1101/gad.252603 · Cited by 165
tBID Homooligomerizes in the Mitochondrial Membrane to Induce Apoptosis
Grinberg, M., Sarig, R., Zaltsman, Y., Frumkin, D., Grammatikakis, N., Reuveny, E., & Gross, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104893200 · Cited by 161
Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
Moriishi, K., Huang, D. C. S., Cory, S., & Adams, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9683 · Cited by 160
Jäger, R., Herzer, U., Schenkel, J., & Weiher, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201353 · Cited by 159
Molecular Prognostic Markers in Pancreatic Cancer
Coppola, D. (2000) · Cancer Control · doi:10.1177/107327480000700504 · Cited by 158
Zhou, P., Qian, L., Bieszczad, C. K., Noelle, R. J., Binder, M., Levy, N. B., & Craig, R. W. (1998) · Blood · doi:10.1182/blood.v92.9.3226 · Cited by 157
Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to Doxorubicin
Panaretakis, T., Tamm, K. P., Shoshan, M. C., & Grandér, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205273200 · Cited by 154
Molecular Comparison of Human and Mouse Pulmonary Adenocarcinomas
Malkinson, A. M. (1998) · Experimental Lung Research · doi:10.3109/01902149809087385 · Cited by 152
BAX and BAK mediate p53-independent suppression of tumorigenesis
Degenhardt, K., Chen, G., Lindsten, T., & White, E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00126-5 · Cited by 151
Choi, S., Park, I. C., Yun, J. W., Sung, Y. C., Hong, S.-I., & Shin, H. S. (1995) · PubMed · Cited by 146
Ravi, R. K., & Bedi, A. (2002) · PubMed · Cited by 145
Gautschi, O. P., Tschopp, S., Olie, R. A., Leech, S. H., Simões‐Wüst, A. P., Ziegler, A., Baumann, B., Odermatt, B. F., Hall, J., Stahel, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.463 · Cited by 145
Strasser, A., Harris, A. W., von Boehmer, H., & Cory, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1376 · Cited by 144
Activation of mitochondrial voltage-dependent anion channel by apro-apoptotic BH3-only protein Bim
Sugiyama, T., Shimizu, S., Matsuoka, Y., Yoneda, Y., & Tsujimoto, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205621 · Cited by 142
Buchholz, T. A., Davis, D. W., McConkey, D. J., Symmans, W. F., Valero, V., Jhingran, A., Tucker, S. L., Pusztai, L., Cristofanilli, M., Esteva, F. J., et al. (2003) · The Cancer Journal · doi:10.1097/00130404-200301000-00007 · Cited by 142
Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice
Sorenson, C. M., Rogers, S. A., Korsmeyer, S. J., & Hammerman, M. R. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.1.f73 · Cited by 135
Solution Structure of Human BCL-w
Denisov, A. Y., Murthy, M. S., Chen, G., Khadir, A., Beauparlant, P., Attardo, G., Shore, G. C., & Gehring, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301798200 · Cited by 132
Matolcsy, A., Casali, P., Warnke, R. A., & Knowles, D. (1996) · Blood · doi:10.1182/blood.v88.10.3937.bloodjournal88103937 · Cited by 131
BH3 Death Domain Peptide Induces Cell Type-selective Mitochondrial Outer Membrane Permeability
Polster, B. M., Kinnally, K. W., & Fiskum, G. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104552200 · Cited by 130
Shibata, M., Liu, M., Knudson, C. M., Shibata, E., Yoshidome, K., Bandey, T., Korsmeyer, S. J., & Green, J. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.10.2692 · Cited by 127
Mutations of the bak gene in human gastric and colorectal cancers.
Kondo, S., Shinomura, Y., Miyazaki, Y., Kiyohara, T., Tsutsui, S., Kitamura, S., Nagasawa, Y., Nakahara, M., Kanayama, S., & Matsuzawa, Y. (2000) · PubMed · Cited by 125
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Ma, Y., Cress, W. D., & Haura, E. B. (2003) · PubMed · Cited by 120
A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of Apoptosis
Hunter, J., & Parslow, T. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8521 · Cited by 118
Sansam, C. G., Chattopadhyay, A., Parkhurst, C., & Yang, E. (2002) · Oncogene · doi:10.1038/sj.onc.1205928 · Cited by 116
Traps to catch unwary oncogenes
Hueber, A., & Evan, G. I. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01520-0 · Cited by 116
Nieborowska-Skorska, M., Hoser, G., Kossev, P. M., Wasik, M. A., & Skórski, T. (2002) · Blood · doi:10.1182/blood.v99.12.4531 · Cited by 116
Molecular prognostic markers in pancreatic cancer
Ghaneh, P., Kawesha, A., Evans, J. D., & Neoptolemos, J. P. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200000 · Cited by 114
Lee, J.-U., Hosotani, R., Wada, M., Doi, R., Kosiba, T., Fujimoto, K., Miyamoto, Y., Tsuji, S., Nakajima, S., Nishimura, Y., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00134-3 · Cited by 114
Tissue expression and subcellular localization of the pro-survival molecule Bcl-w
O’Reilly, L. A., Print, C. G., Hausmann, G., Moriishi, K., Cory, S., Huang, D. C. S., & Strasser, A. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400835 · Cited by 113
Kogan, S. C., Brown, D. E., Shultz, D. B., Truong, B.-T., Lallemand-Breitenbach, V., Guillemin, M.-C., Lagasse, E., Weissman, I. L., & Bishop, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.531 · Cited by 108
D’Sa-Eipper, C., Subramanian, T., & Chinnadurai, G. (1996) · PubMed · Cited by 108
Sturm, I., Petrowsky, H., Volz, R., Lorenz, M., Radetzki, S., Hillebrand, T., Wolff, G., Hauptmann, S., Dörken, B., & Daniel, P. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2272 · Cited by 108
The Molecular Mechanism of Programmed Cell Death in C. elegans
Liu, Q., & Hengartner, M. O. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07925.x · Cited by 106
Yamaguchi, H., & Wang, H.-G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207516200 · Cited by 101
Dominov, J. A., Dunn, J. J., & Miller, J. B. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.537 · Cited by 101
Shangary, S. K., & Johnson, D. E. (2002) · Biochemistry · doi:10.1021/bi025605h · Cited by 100
Jiang, Z., Zheng, X.-F., & Rich, K. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01522.x · Cited by 98
Tumor regression by combination antisense therapy against Plk1 and Bcl-2
Elez, R., Piiper, A., Kronenberger, B., Kock, M., Brendel, M., Hermann, E., Pliquett, U. F., Neumann, E., & Zeuzem, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206038 · Cited by 97
Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients
Gradilone, A., Gazzaniga, P., Ribuffo, D., Scarpa, S., Cigna, E., Vasaturo, F., Bottoni, U., INNOCENZI, D., Calvieri, S., Scuderi, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.066 · Cited by 97
Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins
Moreau, C., Cartron, P., Hunt, A. E., Méflah, K., Green, D. R., Evan, G. I., Vallette, F. M., & Juin, P. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209472200 · Cited by 96
Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL
Vieira, H. L. A., Boya, P., Cohen, I., Hamel, C. E., Haouzi, D., Druillennec, S., Belzacq, A.-S., Brenner, C., Roques, B. P., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205270 · Cited by 94
bcl-2 overexpression promotes myocyte proliferation
Limana, F., Urbanek, K., Chimenti, S., Quaini, F., Leri, A., Kajstura, J., Nadal‐Ginard, B., Izumo, S., & Anversa, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092672899 · Cited by 94
Overexpression of Bcl‐2 in squamous cell carcinoma of the larynx: A marker of radioresistance
Condon, L. T., Ashman, J. N. E., Ell, S. R., Stafford, N. D., Greenman, J., & Cawkwell, L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10503 · Cited by 85
Heere‐Ress, E., Thallinger, C., Lucas, T., Schlagbauer‐Wadl, H., Wacheck, V., Monia, B. P., Wolff, K. S., Pehamberger, H., & Jansen, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10248 · Cited by 85
Bax accelerates tumorigenesis in p53-deficient mice.
Knudson, C. M., Johnson, G. M., Lin, Y.-T., & Korsmeyer, S. J. (2001) · PubMed · Cited by 85
Olie, R. A., Hafner, C., Küttel, R., Sigrist, B., Stahel, R. A., Zangemeister‐Wittke, U., Willers, J., Dummer, R., & Hall, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01677.x · Cited by 83
Role of bcl-2 in the Development of Lymphoid Cells From the Hematopoietic Stem Cell
Matsuzaki, Y., Nakayama, K., Nakayama, K., Tomita, T., 磯田魅卯, Loh, D. Y., & Nakauchi, H. (1997) · Blood · doi:10.1182/blood.v89.3.853 · Cited by 81
Theodorakis, P., Lomonosova, E. E., & Chinnadurai, G. (2002) · PubMed · Cited by 80
Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes
Boudard, D., Vasselon, C., Berthéas, M., Jaubert, J., Mounier, C., Reynaud, J., Viallet, A., Chautard, S., Guyotat, D., & Campos, L. (2002) · American Journal of Hematology · doi:10.1002/ajh.10108 · Cited by 80
Bcl-xL overexpression in human hepatocellular carcinoma
Watanabe, J., Kushihata, F., Honda, K., Mominoki, K., Matsuda, S., & Kobayashi, N. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.3.515 · Cited by 79
Rosen, K. V., Rak, J. W., Jin, J., Kerbel, R. S., Newman, M. J., & Filmus, J. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00564-7 · Cited by 78
Lowe, S., Rubinchik, S., Honda, T., McDonnell, T. J., Dong, J.-Y., & Norris, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301531 · Cited by 78
Uhlmann, E. J., D’Sa-Eipper, C., Subramanian, T., Wagner, A. J., Hay, N., & Chinnadurai, G. (1996) · PubMed · Cited by 77
A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.
Pena, J. C., Rudin, C. M., & Thompson, C. B. (1998) · PubMed · Cited by 71
Sanz, C., Benito, A., Inohara, N., Ekhterae, D., Núñez, G., & Fernández-Luna, J. L. (2000) · Blood · doi:10.1182/blood.v95.9.2742.009k24_2742_2747 · Cited by 68
Bcl-w expression in colorectal adenocarcinoma
Wilson, J. W., Nostro, M. C., Balzi, M., Faraoni, P., Cianchi, F., Becciolini, A., & Potten, C. S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0897 · Cited by 67
Accelerated disappearance of melanocytes in bcl-2-deficient mice.
Yamamura, K., Kamada, S., Ito, S., Nakagawa, K., Ichihashi, M., & Tsujimoto, Y. (1996) · PubMed · Cited by 66
Cited by
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
A decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Ola, M. S., Nawaz, M., & Ahsan, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0709-x · Cited by 920
Metadata
- Authors
- Kirkin, V., Joos, S., & Zörnig, M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 1644
- Issue
- 2-3
- Pages
- 229-249
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2060796398
- Cited by
- 548
- References
- 214
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.